The organization’s “Link Program” consists of multiple intervention components that are designed to benefit the target population which includes: women carrying BRCA1/2 gene mutations; women who are unaffected with HBOC but at increased genetic risk (“previvors”); women surviving with breast/ovarian cancer; and especially HBOC and YBCS, mBC patients, and cancer caregivers. The gene discussed is BRCA1; the disease is ovarian cancer.